Ardent Health, Inc. (NYSE:ARDT) Receives Consensus Recommendation of “Moderate Buy” from Analysts

Ardent Health, Inc. (NYSE:ARDT) has been given a consensus rating of “Moderate Buy” by the twelve ratings firms that are presently covering the company, MarketBeat reports. Two research analysts have rated the stock with a sell recommendation, one has given a hold recommendation and nine have given a buy recommendation to the company. The average 12 month price target among brokers that have issued a report on the stock in the last year is $19.3273.

ARDT has been the subject of several recent research reports. JPMorgan Chase & Co. decreased their price objective on Ardent Health from $18.00 to $15.00 and set a “neutral” rating for the company in a report on Monday, August 11th. Bank of America downgraded Ardent Health from a “neutral” rating to an “underperform” rating and decreased their price objective for the company from $15.50 to $14.60 in a report on Wednesday, July 16th. KeyCorp decreased their price objective on Ardent Health from $24.00 to $20.00 and set an “overweight” rating for the company in a report on Thursday, August 7th. Weiss Ratings restated a “sell (d+)” rating on shares of Ardent Health in a report on Wednesday. Finally, UBS Group initiated coverage on Ardent Health in a report on Wednesday, September 10th. They issued a “buy” rating and a $17.00 price objective for the company.

Hedge Funds Weigh In On Ardent Health

Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. CWM LLC grew its stake in Ardent Health by 990.6% in the second quarter. CWM LLC now owns 2,203 shares of the company’s stock valued at $30,000 after purchasing an additional 2,001 shares during the last quarter. Morse Asset Management Inc purchased a new position in Ardent Health in the first quarter valued at about $36,000. Quarry LP grew its stake in Ardent Health by 1,519.4% in the first quarter. Quarry LP now owns 5,020 shares of the company’s stock valued at $69,000 after purchasing an additional 4,710 shares during the last quarter. New York State Common Retirement Fund grew its stake in Ardent Health by 121.4% in the second quarter. New York State Common Retirement Fund now owns 6,200 shares of the company’s stock valued at $85,000 after purchasing an additional 3,400 shares during the last quarter. Finally, Deutsche Bank AG grew its stake in Ardent Health by 140.1% in the first quarter. Deutsche Bank AG now owns 6,882 shares of the company’s stock valued at $95,000 after purchasing an additional 4,016 shares during the last quarter.

Ardent Health Stock Down 1.8%

NYSE:ARDT opened at $14.08 on Friday. Ardent Health has a twelve month low of $10.10 and a twelve month high of $20.72. The company has a market cap of $2.01 billion, a price-to-earnings ratio of 7.78, a price-to-earnings-growth ratio of 6.34 and a beta of 0.39. The stock has a fifty day simple moving average of $12.91 and a 200-day simple moving average of $13.04. The company has a current ratio of 2.13, a quick ratio of 2.00 and a debt-to-equity ratio of 0.66.

Ardent Health (NYSE:ARDT) last released its earnings results on Tuesday, August 5th. The company reported $0.52 earnings per share for the quarter, topping the consensus estimate of $0.30 by $0.22. The business had revenue of $1.65 billion during the quarter, compared to the consensus estimate of $1.54 billion. Ardent Health had a return on equity of 16.66% and a net margin of 4.11%. Ardent Health has set its FY 2025 guidance at 1.730-2.01 EPS. Analysts anticipate that Ardent Health will post 1.23 EPS for the current year.

Ardent Health Company Profile

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.